Ultraviolet B, not A, radiation triggers melanoma

Key points
- Experiments with mice show that ultraviolet A (UVA) radiation does not initiate melanoma skin cancer, but ultraviolet B (UVB) does.
- De Fabo of The George Washington University Medical Center, Washington DC, and colleagues, exposed mice to light of various wavelengths.
- Melanoma was triggered most strongly by the UVB lamp, followed by the solar simulator and the sunlamp, which both had comparable melanoma-inducing properties, De Fabo's group reports in the September 15th issue of Cancer Research.
- In contrast, mice exposed to UVA light or to the filtered sunlamp had responses no different from those of a comparison group of animals that were not exposed to any of the light sources.
Experiments with mice show that ultraviolet A (UVA) radiation does not initiate melanoma skin cancer, but ultraviolet B (UVB) does.
Dr. Edward C. De Fabo of The George Washington University Medical Center, Washington DC, and colleagues, exposed mice to light of various wavelengths. This included UVA, UVB, solar simulation, an unfiltered sunlamp, and a sunlamp filtered to remove more than 96 percent of the UVB spectrum.
Melanoma was triggered most strongly by the UVB lamp, followed by the solar simulator and the sunlamp, which both had comparable melanoma-inducing properties, De Fabo's group reports in the September 15th issue of Cancer Research.
In contrast, mice exposed to UVA light or to the filtered sunlamp had responses no different from those of a comparison group of animals that were not exposed to any of the light sources.
"Considerable controversy exists as to which wavelengths in the sunlight spectrum initiate melanoma," De Fabo told Reuters Health. "This paper points out clearly that UVB is the culprit whereas UVA was ineffective."
The findings are "essential for accurately determining the melanoma risk of exposure to sunlight or suntanning lamps," he added.
Furthermore, "By contrasting the molecular effects of UVB and UVA radiation, genes linked to melanoma initiation should be more readily identifiable."
SOURCE: Cancer Research, September 15 2004.
Written and revised by
Gerald Hurowitz, M.D.
Our doctors write and review articles for accuracy and keep them up to date.
health.am provides general information, not medical advice. Always consult a qualified health professional about your own health.
Explore health topics
More in this topic
Cancer →
NewsDiabetes drug metformin with chemo and radiation may improve outcomes in lung cancer patients
Treating aggressive lung cancer with the diabetes drug metformin along with radiation and chemotherapy may slow tumor growth and recurrence, suggests new preliminary findings from researchers at the Perelman School of…
24 October 2013
NewsLight triggers death switch in cancer cells
Researchers at Cardiff University have created a peptide (a small piece of protein), linked to a light-responsive dye, capable of switching 'on' death pathways in cancer cells. The peptide remains inactive until exposed…
17 October 2013
NewsAfter melanoma, people head back to the sun: study
People with the most dangerous type of skin cancer tend to stay out of the sun and wear extra sunscreen the year after being diagnosed. But a new small study suggests those precautions don't last. Two to three years…







